Brief: Dianthus Therapeutics Announces Proposed $400 Million Underwritten Public Offering
09/03/2026 21:59
March 9 (Reuters) - Dianthus Therapeutics Inc DNTH.O: DIANTHUS THERAPEUTICS, INC. ANNOUNCES PROPOSED $400 MILLION UNDERWRITTEN PUBLIC OFFERING DIANTHUS THERAPEUTICS INC - TO USE NET PROCEEDS FOR CLINICAL, COMMERCIAL, WORKING CAPITAL, AND CORPORATE PURPOSES Source text: ID:nGNX1sgc7B Further company coverage: DNTH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dianthus Therapeutics
See all newsU.S. RESEARCH ROUNDUP- Adobe, Chewy, Mosaic
Brief: Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
Dianthus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dianthus Therapeutics Q2 net loss widens as R&D costs rise